Pharma-Kühlkettenmanagement: Sicheres Handling & Intelligente Innovationen in 2025
Aktualisiert: November 2025
Jede Lieferung von Impfstoffen, Biologika oder Gentherapien sind auf eine ununterbrochene temperaturkontrollierte Kette angewiesen. Management der Pharma-Kühlkette isn’t just a buzzword; it’s a critical practice that safeguards drug potency, protects public health and satisfies global regulations. In 2025 the stakes are higher than ever—forecasts estimate the pharmaceutical coldchain market will exceed UNS $65 Milliarde and double by 2034. With more cell and gene therapies requiring ultracold conditions, you need a robust strategy to maintain 2 ° C bis 8 °C for vaccines or down to –150 °C for advanced therapies. This guide breaks down what matters most, from temperature ranges and mean kinetic temperature to Good Distribution Practice (BIP), DSCSA-Fristen, IoT innovations and sustainable packaging. You’ll learn practical steps to protect your cargo, meet regulators’ expectations and boost operational efficiency.

Why is cold chain management critical for pharmaceuticals? – Understand how temperature excursions damage product quality and why nearly 43 % of newly approved drugs require cold storage.
What temperature ranges and storage definitions apply? – Learn the differences between refrigerators (2 °C–8 °C), Gefriergeräte (–25 °C bis –10 °C), ultracold freezers (–90 °C bis –60 °C) and cryogenic storage.
How do GDP, USP <1079.2> und die USA. DSCSA shape compliance? – Explore mandatory electronic tracking by August 27 2025, mean kinetic temperature guidelines and global calibration standards.
Welche Technologien verändern die Kühlkettenlogistik?? – Discover how IoT sensors, KI-Routenoptimierung, blockchain and drones prevent spoilage and improve visibility.
How can you implement a resilient cold chain system? – Follow stepbystep advice on packaging, kontinuierliche Überwachung, Dokumentation und Notfallplanung.
Why Is Cold Chain Management Essential for Pharmaceuticals?
Protecting drug efficacy and patient safety
Temperature excursions quickly degrade biologics and vaccines. According to the American Society of HealthSystem Pharmacists, über 43 % von 292 drugs approved between January 2018 und März 2023 erfordern eine Art Kühllagerung, Und 6 % need freezing or ultracold conditions. Many vaccines lose potency if exposed below freezing or above 8 °C; gene and cell therapies may become inactive if temperatures rise above –70 °C. Weltweit, the World Health Organization estimates that up to 50 % of vaccines are wasted annually due to inadequate temperature control and logistics—a statistic that underscores the public health risk of poor coldchain management.
Darüber hinaus, Die Biopharma Cold Chain Sourcebook reports that temperaturecontrolled logistics accounted for nearly 18 % der Biopharma-Logistikausgaben in 2020. With rising investments in cell and gene therapies that require ultracold storage (often below –80 °C), the market is projected to surpass UNS $81 Milliarde von 2029. These figures illustrate how critical cold chain logistics have become for financial performance and patient outcomes.
Economic impacts of coldchain failures
When temperatures drift outside the recommended range, Produkte verschlechtern sich, zu finanziellen Verlusten führen, regulatory penalties and wasted inventory. Die USA. Gesetz zur Sicherheit der Arzneimittellieferkette (DSCSA) warns that mismatches between electronic data and physical product identifiers can halt shipments and trigger costly quarantines. Industry estimates suggest DSCSArelated errors could cost more than UNS $6 Milliarde annually due to stalled shipments, entgangene Verkäufe und manuelle Korrekturen. Beyond direct costs, brand reputation suffers when patients receive ineffective medications. A robust coldchain strategy preserves both revenue and public trust.
Understanding Temperature Requirements and Storage Definitions
Regulatory definitions of storage conditions
Die USA. Pharmakopöe (USP) defines key temperature categories that underpin pharmaceutical coldchain management. A Kühlschrank is a unit that maintains temperatures between 2 °C und 8 °C (36 °F–46 °F), während a Gefrierschrank maintains –25 °C bis –10 °C. Kalt storage refers to any temperature not exceeding 8 °C, Und Cool conditions lie between 8 °C und 15 °C. Kontrollierte Raumtemperatur (CRT) ranges from 20 ° C bis 25 °C with permitted excursions up to 40 °C for short durations. Die Zentren für Krankheitskontrolle und Prävention (CDC) further specify that ultracold freezers used for some COVID19 vaccines must keep products between –90 °C und –60 °C, and standard freezers should stay between –50 °C und –15 °C.
Mittlere kinetische Temperatur (Mkt) and excursion evaluation
Verständnis mean kinetic temperature (Mkt) is essential for assessing temperature excursions. USP <1079.2>, released in August 2025, provides clear guidance on evaluating excursions using MKT. Für kontrollierte Raumtemperatur (CRT) Produkte, the maximum range is 15 °C–30 °C with a temporary excursion up to 40 °C for no more than 24 Std.; Der 30-Tage-MKT darf nicht überschritten werden 25 °C. Für controlled cold temperature (CCT) Produkte, the acceptable range is 2 °C–8 °C, with excursions up to 15 °C allowed for 24 Std.; the 24hour MKT must remain below 8 °C. Each excursion must be treated as a nonconforming event, requiring investigation and documentation. Understanding MKT helps you determine whether corrective action is needed or whether products remain within safe limits.
Typical temperature ranges for different products
| Produkttyp | Empfohlener Lagerbereich | Auswirkungen von Abweichungen | Praktische Implikationen |
| Standardimpfstoffe (Z.B., Grippe) | +2 ° C bis +8 °C | Einfrieren kann irreversible Reaktionen hervorrufen; Überhitzung verringert die Potenz | Sorgen Sie für Kühlung, Vermeiden Sie das Einfrieren, and monitor continuously |
| HPV-Impfstoffe | +2 ° C bis +8 °C | Dauerhafter Potenzverlust bei Einfrieren | Verwenden Sie kalibrierte Thermometer und Alarme, um Abweichungen zu verhindern |
| Covid-19 Impfungen (Pfizer) | –80 °C bis –60 °C | Wirkungsverlust bei Temperaturanstieg | Investieren Sie in tragbare kryogene Lagerung und validierte Versandlösungen |
| Covid-19 Impfungen (Modern) | –25 °C bis –15 °C zur Langzeitlagerung; 2 °C–8 °C für bis zu 30 Tage | Eine längere Lagerung bei Raumtemperatur verkürzt die Haltbarkeit | Planen Sie die Versanddauer und die Lagerzeiten vor Ort sorgfältig |
| Gen & Zelltherapien | –70 °C oder niedriger | Der Abbau führt zum Verlust des therapeutischen Wertes | Verwenden Sie spezielle kryogene Gefriergeräte und Echtzeitüberwachung |
These ranges illustrate the diversity of temperature demands within pharmaceutical cold chain management. Many standard biologics require refrigeration, but cuttingedge cell therapies often need –80 °C oder niedriger, making portable cryogenic solutions vital.
Regulatorische Rahmenbedingungen: BIP, DSCSA and Global Guidelines
Gute Vertriebspraxis (BIP) Prinzipien
GDP guidelines enforced by the EMA, FDA and WHO govern how medicines are stored, transportiert und gehandhabt. Core principles include: Aufrechterhaltung der Temperaturkontrolle (Typischerweise 2 °C–8 °C), using qualified equipment, kontinuierliche Überwachung, Risikobewertung, Schulung und Dokumentation. Companies must implement validated packaging solutions, calibrate monitoring devices and establish contingency plans for power outages or equipment failures. Echtzeitüberwachung, validated packaging and regular audits are essential to demonstrate compliance.
DSCSA: Electronic traceability and final deadlines
Der UNS. Gesetz zur Sicherheit der Arzneimittellieferkette (DSCSA) mandates an interoperable system for tracking prescription drugs at the package level. Signed in 2013, it phases in requirements culminating in full implementation by August 27 2025 for wholesale distributors, with large dispensers following by November 27 2025 and small dispensers by November 27 2026. Key obligations include:
Transaktionsdaten sicher austauschen – Stakeholders must send and receive transaction information and statements electronically using the EPCIS standard.
Überprüfen Sie die Produktkennzeichnungen – Every saleable unit’s Global Trade Item Number (GTIN), Seriennummer, lot number and expiration date must be authenticated.
Stellen Sie die Datengenauigkeit sicher – Electronic data must match the physical product; mismatches trigger quarantines and fines up to UNS $500,000.
Phasein schedule – Manufacturers must comply by May 27 2025, Großhändler bis August 27 2025, large dispensers by November 27 2025 and small dispensers by November 27 2026.
Failing to comply may lead to shipment delays, license suspension or imprisonment. DSCSA also pushes digital transformation: companies should adopt systems that integrate transaction data, serialisation and realtime temperature monitoring.
Global regulations and WHO guidelines
Outside the United States, the European Union’s GDP and GMP Annex 11 require validated electronic systems with audit trails and secure access. Viele Länder übernehmen die Richtlinien der WHO zur Lagerung von Impfstoffen, which recommend digital monitoring and documentation. For COVID19 vaccines, the Pfizer–BioNTech formulation requires –80 °C bis –60 °C storage while Moderna’s vaccine requires –25 °C bis –15 °C long term. Complying with these standards ensures international shipments maintain integrity across borders.
Technologies Transforming Cold Chain Logistics in 2025
IoT und Echtzeit-Tracking
Realtime visibility is the bedrock of modern cold chain management. Internet der Dinge (IoT) Sensoren continuously collect temperature, Luftfeuchtigkeit und Standortdaten. Trackonomy notes that realtime tracking enables route optimisation, Reduziert den Abfall, indem es den Verderb verhindert, und hilft Unternehmen dabei, gesetzliche Anforderungen zu erfüllen. Wenn Sensoren unsichere Temperaturniveaus erkennen, they send alerts via texting platforms or mobile apps, allowing staff to intervene before product quality is compromised.
IoT platforms also support prädiktive Analytik: by analysing historical and live data, algorithms can forecast equipment failures, Reduzierung ungeplanter Ausfallzeiten um bis zu 50 % und Senkung der Reparaturkosten um 10–20 %. Zum Beispiel, sensors embedded in coldchain trucks can predict when compressors will fail and schedule maintenance before breakdowns occur, Vermeidung von Temperaturschwankungen.
Künstliche Intelligenz (Ai) und prädiktive Analysen
Artificial Intelligence enhances logistics by optimising routes, Prognose der Nachfrage und Antizipation von Geräteausfällen. Die KI-gestützte Routenoptimierung nutzt Echtzeit-Verkehrs- und Wetterdaten, um den schnellsten Weg auszuwählen, Reduzierung der Transportzeit und des Verderbsrisikos. Vorausschauende Wartungsmodelle identifizieren bevorstehende Geräteprobleme, while AIbased demand forecasting helps manufacturers plan production and shipping volumes. By comparing temperature data with regulatory ranges, AI can automatically flag noncompliant shipments. These capabilities improve reliability and free personnel to focus on highvalue tasks.
Blockchain und Datenintegrität
Blockchain technology ensures endtoend traceability and tamperproof data sharing. Die Temperatur jeder Sendung, humidity and transit time are recorded in an immutable ledger accessible to manufacturers, carriers and health providers. Blockchain prevents data manipulation and counters counterfeit drugs. In Südostasien, blockchain adoption provides realtime monitoring and transparency for vaccine shipments. Durch die Integration von Blockchain mit IoT-Sensoren, stakeholders can quickly verify that a product stayed within its required temperature range, simplifying audits and strengthening trust.
Drones and remote deliveries
Delivering medicines to remote or disasteraffected regions poses challenges. Drone technology offers contactless, rapid delivery, Sicherstellen, dass temperaturempfindliche Produkte die Patienten schnell und sicher erreichen. B Medical Systems notes that drones allow traceable deliveries of vaccines and reduce lastmile disruptions. Some drones include builtin refrigeration units and IoT trackers to maintain temperature integrity throughout flight. Da sich die regulatorischen Rahmenbedingungen weiterentwickeln, drones are becoming an increasingly viable solution for rural healthcare.
Portable cryogenic freezers and ultracold solutions
Advanced cell and gene therapies require temperatures below –80 °C. Tragbare kryogene Gefriergeräte maintain –80 °C to –150 °C even in challenging environments. Their compact form allows onthego transportation during fieldwork or clinical trials. These freezers offer realtime temperature tracking and alarm notifications, ensuring regulatory compliance and protecting product potency. Such innovations enable therapies to reach remote areas without relying on large infrastructure.
Sustainable energy and ecofriendly packaging
Energy consumption and waste are critical concerns in cold chain logistics. Auf die Kühlung entfallen ca 2 % der weltweiten CO₂-Emissionen. To cut emissions and meet netzero goals, Unternehmen übernehmen dies solarbetriebene Kühllagereinheiten Und Biologisch abbaubare Verpackungen. Solarpowered units provide costeffective storage in regions with unreliable power grids and reduce energy costs. Mehrwegbehälter, Vakuumisolationsgremien (VIPs) und Phasenwechselmaterialien (PCMs) bieten überlegene thermische Stabilität und weniger Abfall. Reusable pallet shippers like Peli BioThermal’s Credo Cube™ maintain ultracold temperatures for over 144 hours while reducing dry ice use by 75 %.
Automatisierung, robotics and smart warehouses
Arbeitskräftemangel und steigende Nachfrage zwingen Lager zur Automatisierung. In 2025, nur etwa 20 % der Kühllageranlagen sind vollautomatisiert. Robotics and automated picking systems improve throughput, Fehler reduzieren und Arbeiter vor extremen Temperaturen schützen. Fahrerlose Transportfahrzeuge (AGVs) und Roboterarme bewegen Waren zwischen Gefrierschränken und Bereitstellungsbereichen, erlauben 24/7 Operationen. Combined with AIdriven scheduling, Die Automatisierung unterstützt die Just-in-Time-Lieferung und verhindert Staus.
Integration of sustainable supply chains
The movement toward netzero supply chains is accelerating. Regierungen, investors and health organisations are pressuring pharmaceutical companies to decarbonize logistics. Cold chain and logistics segments dominate netzero efforts because sustainable logistics reduce spoilage and carbon emissions. Europe leads this market due to stringent regulations, while AsiaPacific is the fastest growing region thanks to largescale investment in green manufacturing and renewable energy. To achieve netzero, companies deploy carbontracking software, optimise transportation routes and integrate renewable energy sources into facilities.
Components of a Reliable Cold Chain System
Implementing a robust cold chain requires layering physical equipment with digital monitoring, Dokumentation und geschultes Personal. Key components include:
Temperaturregelung & Stabilität – Use reliable refrigeration units and passive packaging (Isolierte Behälter, Palettenversender, Phasenwechselmaterial) to maintain stable conditions from manufacturing to administration. Ultrakalte Produkte benötigen möglicherweise kryogene Gefriergeräte und Trockeneis; Stellen Sie sicher, dass die Verpackung für die erforderliche Dauer validiert ist.
Kontinuierliche Überwachung – Deploy sensors, Datenlogger und IoT-Geräte, die kontinuierlich Temperatur und Luftfeuchtigkeit aufzeichnen. Die Echtzeitüberwachung ermöglicht schnelle Korrekturmaßnahmen; predictive analytics can lower repair costs and reduce unplanned downtime by up to 50 %.
Nachvollziehbare Dokumentation – Maintain digital records of temperature data, Handhabungsverfahren und Korrekturmaßnahmen. DSCSA erfordert einen sicheren elektronischen Datenaustausch und serialisierte Produktkennzeichnungen.
Validierte Ausrüstung & Prozesse – Ensure monitoring devices and packaging solutions are calibrated to recognised standards like NIST or UKAS. Verpackungspartner sollten Qualifikationsdaten bereitstellen und die GDP- und IATA-Anforderungen einhalten.
Geschultes Personal – Continuous training ensures personnel understand temperature requirements, handling protocols and emergency responses.
Notfallplanung – Develop protocols for equipment failures, Stromausfälle und Verzögerungen. Bauen Sie Redundanz mit Backup-Generatoren auf, zusätzliche Sensoren und alternative Transportwege.
Nachhaltige Praktiken – Choose reusable packaging and energyefficient refrigeration systems to reduce carbon footprint and comply with netzero commitments.
Best practices for packaging and transport
Selecting the right packaging is crucial for maintaining temperatures. Isolierte Behälter account for roughly 40 % des Marktes für Kühlkettenverpackungen, während Palettenversender represent about 25 %. Phasenwechselmaterial (PCMs) and VIPs provide precise temperature control, and smart packaging platforms use AI and IoT to recommend appropriate solutions. Cryovac vacuum-sealed packaging reduces plastic use and extends shelf life. Bei der Auswahl eines Lieferanten, verify that their solutions meet ISTA 7D or GDP standards and that they offer reusable options to lower cost and waste.
Für den Transport, passive cooling solutions like dry ice, liquid nitrogen and gel packs provide reliable temperature control and can be replenished during transit. Realtime trackers and tamperevident seals maintain security. Route planning should account for expected temperature exposure, ensuring that shipments arrive within hold times. Für Lieferungen auf der letzten Meile, consider drones or local refrigerated vehicles equipped with IoT sensors.
Realworld tips and advice
Kurzstrecken-Stadtlieferungen: Nutzen Sie IoT-fähige Palettenversender mit Gelpacks; Sensoren senden Warnungen, wenn die Temperaturen schwanken.
Fern- oder Landtransporte: Kombinieren Sie tragbare kryogene Gefriergeräte mit solarbetriebener Speicherung, um Strominstabilität zu überwinden.
Hochwertige Biologika: Employ reusable VIP containers and cryogenic shippers like Crēdo Cube™, which maintain ultracold conditions for over 144 hours and cut dry ice by 75 %.
Crossborder transport: Align with both DSCSA and EU GDP requirements, ensuring that electronic data exchange and calibration meet international standards.
Praktischer Fall: A small biotech firm shipping a gene therapy from California to a clinical site in rural Africa used a portable cryogenic freezer combined with IoT sensors. The freezer maintained –100 °C for 48 hours and sent realtime temperature updates via satellite. When a sensor detected a gradual rise due to a stuck compressor, the operations team rerouted the package through a nearby hub with backup freezers. The therapy arrived intact, and the firm avoided product loss and regulatory penalties. This case shows how monitoring and contingency plans protect both patient safety and company revenue.
2025 Market Insights and Emerging Trends
Growth drivers and market size
Der Markt für pharmazeutische Kühlketten wächst rasant. Precedence Research estimates that the global cold chain packaging sector will grow from UNS $20.05 Milliarden in 2025 Zu UNS $69.55 Milliarden von 2034, eine durchschnittliche jährliche Wachstumsrate (CAGR) von 14.82 %. Ähnlich, the broader cold chain monitoring market is expected to surge from UNS $45.19 Milliarden in 2025 Zu UNS $266.66 Milliarden von 2034, with North America currently holding 35 % Marktanteil. Asia–Pacific is projected to grow fastest due to investment in biologics and gene therapies and the adoption of digital tracking.
Drivers of this growth include increased production of biologics, vaccines and CGTs; expansion of ecommerce pharmacies; strengere Vorschriften; and innovations in packaging and monitoring. In 2025, cell and gene therapies often require ultracold transport (unter –80 °C), contributing to the rise of cryogenic shipping equipment. Rising demand for GLP1 weightloss drugs, which must be stored between 2 °C und 8 °C, also boosts coldchain requirements.
Trends shaping cold chain logistics
Automatisierung und Robotik: Weniger als 20 % of cold warehouses are automated, leaving room for robots and automated guided vehicles to improve throughput and labour safety.
End-to-End-Sichtbarkeit: Ai, IoT and blockchain deliver realtime tracking and predictive alerts, Reduzierung des Verderbs und Verbesserung der Compliance.
Nachhaltigkeit: Governments and investors demand carbonneutral logistics. Companies adopt renewable energy, biodegradable packaging and reusable containers, and Europe’s netzero initiatives set the pace.
Advanced therapies: Cell and gene therapies require ultracold conditions; portable cryogenic freezers and reusable shippers support this need.
Widerstandsfähigkeit der Lieferkette: Climate change increases disease outbreaks and supply disruptions; robust logistics networks and contingency plans mitigate risks.
Digitale Compliance: DSCSA implementation drives electronic data exchange and serialisation, forcing companies to upgrade their IT infrastructure.
Nachhaltige Verpackungsinnovationen: Reusable pallets, ecofriendly phase change materials and vacuum insulation panels reduce waste and support ESG goals.
Market and regional insights
Der netzero pharma supply chain is gaining traction as governments and investors push for decarbonisation. The cold chain and logistics segment dominated this niche market in 2024 because sustainable logistics reduce spoilage and emissions. Europe holds the largest share due to stringent regulations, while AsiaPacific is the fastest growing region due to green manufacturing investments. To meet netzero goals, companies adopt AIdriven logistics, Blockchain, energyefficient refrigeration and renewable power sources.
Häufig gestellte Fragen
Q1: What is pharma cold chain management?
It’s the coordination of systems, equipment and procedures that keep temperaturesensitive medicines within specified ranges from manufacturing to administration. Management der Pharma-Kühlkette involves refrigeration, freezing and ultracold storage (Z.B., –25 °C to –10 °C or –70 °C and below), kontinuierliche Überwachung, regulatory compliance and trained personnel.
Q2: Why do gene and cell therapies need ultracold temperatures?
These advanced therapies contain fragile biological materials that degrade quickly at higher temperatures. Many require storage between –80 °C und –150 °C, and even brief warming can render them ineffective. Portable cryogenic freezers and reusable ultracold shippers preserve potency during transport.
Q3: How does DSCSA impact my logistics operations?
Von August 27 2025, wholesale distributors must exchange transaction data electronically and verify product identifiers for each saleable unit. Noncompliance can lead to fines up to UNS $500,000 and shipment quarantines. You should implement interoperable data platforms, serialisation, secure authentication and realtime temperature monitoring to meet these requirements.
Q4: What are the benefits of using IoT sensors in cold chain management?
IoT devices provide continuous temperature, Luftfeuchtigkeit und Standortdaten. Realtime alerts enable immediate corrective action, Verderb verringern. Predictive analytics lower equipment downtime by up to 50 % and repair costs by 10–20 %.
Q5: Wie kann ich meine Kühlkette nachhaltiger gestalten??
Nehmen Sie wiederverwendbare Verpackungen an, solarpowered storage and renewable energy. Use phase change materials and vacuum insulation panels to minimise dry ice consumption. Implement carbontracking software to measure emissions and choose shipping routes that reduce fuel use. Europe’s netzero initiatives show that sustainable logistics can cut emissions while maintaining compliance.
Zusammenfassung & Empfehlungen
Cold chain management is the linchpin of safe pharmaceutical distribution. In 2025, a surge in biologics, vaccines and cell therapies drives greater demand for refrigeration, freezing and cryogenic storage. Regulatory frameworks—USP <1079.2>, GDP and DSCSA—set strict requirements for temperature control, documentation and electronic traceability. Neue Technologien wie IoT-Sensoren, Ai, blockchain and drones enable realtime monitoring, predictive maintenance and tamperproof tracking. Sustainable practices and automation reduce carbon footprints and labour challenges, while market forecasts point to rapid growth and the expansion of netzero supply chains.
Action plan for your organisation
Assess your product portfolio: Identify temperature ranges and hold times for each product (Z.B., 2 °C–8 °C or –80 °C and below). Use MKT calculations to evaluate excursions.
Überwachungssysteme aufrüsten: Implementieren Sie IoT-Sensoren, data loggers and cloud platforms for continuous tracking, Predictive Analytics und Compliance-Reporting.
Stellen Sie die Einhaltung gesetzlicher Vorschriften sicher: Align with GDP, DSCSA and global guidelines; implement serialization, electronic data exchange and training.
Choose validated packaging: Select reusable containers, cryogenic shippers and phase change materials that meet ISTA 7D or GDP standards.
Entwickeln Sie Notfallpläne: Bereiten Sie sich auf Geräteausfälle vor, power outages and route disruptions with backup generators, zusätzliche Sensoren und alternative Transportwege.
Investieren Sie in Nachhaltigkeit: Adopt solarpowered storage, biodegradable packaging and carbontracking software. Align with netzero initiatives to reduce emissions and appeal to investors.
By implementing these steps, you will ensure product integrity, Einhaltung gesetzlicher Vorschriften und betriebliche Effizienz. The future of pharma cold chain management hinges on combining rigorous temperature control with cuttingedge technology and sustainable practices.
Über Tempk
Tempk is a leader in innovative cold chain packaging and monitoring solutions. Our research and development teams focus on creating ecofriendly, wiederverwendbare Isolierboxen, gel packs and phase change materials that maintain temperature stability during longdistance shipping. With certified quality management systems and compliance with BIP, Iata Und DSCSA Standards, we provide customised solutions for pharmaceuticals, biologics and food applications. Unser Credo Cube™ inspired cryogenic shippers offer ultracold performance with reduced dryice consumption. We’re committed to helping you meet sustainability goals without compromising product safety. Reach out to our experts for tailored advice on building a resilient and compliant cold chain.
Bereit, Ihre Kühlkette zu stärken?
Contact Tempk today for a personalised consultation and explore how our packaging and monitoring solutions can protect your products, Reduzieren Sie Verschwendung und unterstützen Sie die Einhaltung von Vorschriften. Gemeinsam können wir eine sicherere Lösung schaffen, more sustainable pharmaceutical supply chain.